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Self-selection vs Randomized Assignment of Treatment for Appendicitis
Writing Group for the CODA Collaborative
Invited Commentary
IMPORTANCE For adults with appendicitis, several randomized clinical trials have
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demonstrated that antibiotics are an effective alternative to appendectomy. However, it
remains unknown how the characteristics of patients in such trials compare with those of
patients who select their treatment and whether outcomes differ.
OBJECTIVE To compare participants in the Comparison of Outcomes of Antibiotic Drugs and

Appendectomy (CODA) randomized clinical trial (RCT) with a parallel cohort study of
participants who declined randomization and self-selected treatment.
DESIGN, SETTING, AND PARTICIPANTS The CODA trial was conducted in 25 US medical centers.
Participants were enrolled between May 3, 2016, and February 5, 2020; all participants were
eligible for at least 1 year of follow-up, with all follow-up ending in 2021. The randomized
cohort included 1094 adults with appendicitis; the self-selection cohort included patients
who declined participation in the randomized group, of whom 253 selected appendectomy
and 257 selected antibiotics. In this secondary analysis, characteristics and outcomes in both
self-selection and randomized cohorts are described with an exploratory analysis of cohort
status and receipt of appendectomy.
INTERVENTIONS Appendectomy vs antibiotics.
MAIN OUTCOMES AND MEASURES Characteristics among participants randomized to either
appendectomy or antibiotics were compared with those of participants who selected their
own treatment.
RESULTS Clinical characteristics were similar across the self-selection cohort (510 patients;
mean age, 35.8 years [95% CI, 34.5-37.1]; 218 female [43%; 95% CI, 39%-47%]) and the
randomized group (1094 patients; mean age, 38.2 years [95% CI, 37.4-39.0]; 386 female
[35%; 95% CI, 33%-38%]). Compared with the randomized group, those in the self-selection
cohort were less often Spanish speaking (n = 99 [19%; 95% CI, 16%-23%] vs n = 336 [31%;
95% CI, 28%-34%]), reported more formal education (some college or more, n = 355 [72%;
95% CI, 68%-76%] vs n = 674 [63%; 95% CI, 60%-65%]), and more often had commercial
insurance (n = 259 [53%; 95% CI, 48%-57%] vs n = 486 [45%; 95% CI, 42%-48%]). Most
outcomes were similar between the self-selection and randomized cohorts. The number of
patients undergoing appendectomy by 30 days was 38 (15.3%; 95% CI, 10.7%-19.7%) among
those selecting antibiotics and 155 (19.2%; 95% CI, 15.9%-22.5%) in those who were
randomized to antibiotics (difference, 3.9%; 95% CI, −1.7% to 9.5%). Differences in the rate
of appendectomy were primarily observed in the non-appendicolith subgroup.
CONCLUSIONS AND RELEVANCE This secondary analysis of the CODA RCT found substantially
similar outcomes across the randomized and self-selection cohorts, suggesting that the
randomized trial results are generalizable to the community at large.
TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT02800785

Group Information: The CODA
Collaborators are listed in
Supplement 2.
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R

andomized clinical trials (RCTs) are the criterion standard for comparing interventions, but narrow inclusion and exclusion criteria and self-selection frequently fail to reflect the at-risk population. Selection bias
leading to differences between study and target populations
can limit the generalizability of trial findings and may explain differential outcomes between RCTs and self-selection
cohort studies. For treating appendicitis in adults, 9 RCTs1-9
have shown that appendectomy can usually be avoided with
antibiotics. In the only large-scale US trial to date, 71% of participants treated with antibiotics did not undergo appendectomy by 90 days.10 The largest European trial conducted in a
lower-risk group (excluding those with appendicolith) found
61% avoided surgery by 5 years.11 In contrast, a large observational cohort study based on commercial claims data found
avoidance of appendectomy after antibiotics in nearly 94% of
patients over 3 years.12 Another small observational study using
clinical data13 found that among 159 patients treated with antibiotics, by 2 years, appendectomy was avoided in 86%.
Although selection bias may explain some of these differences, the lower rate of appendectomy identified in observational studies of antibiotics may also relate to patient belief that
the treatment they select will work for them.14 Given that patients usually select their own treatment, observational studies may provide context for the results of RCTs. Including participants in research who decline randomization but agree to
participate in a parallel observational cohort study can help identify the magnitude of any selection bias and potentially characterize the influence of treatment choice on outcomes. A parallel observational (self-selection) cohort may be especially
informative when treatment arm crossover is possible or when
a patient’s subjective response is the outcome of interest.
The Comparison of Outcomes of Antibiotic Drugs and
Appendectomy (CODA) trial—a pragmatic, nonblinded, noninferiority RCT—randomized 1552 patients with the type of appendicitis commonly treated with appendectomy to either appendectomy or antibiotics.10,15 In CODA, antibiotics were found
to be noninferior to appendectomy when considering a 5domain generic global health-status measure (EQ-5D)16 at 30
days, with a similar rate of serious adverse events across study
groups (2%).10 CODA included a parallel self-selection cohort
of 510 patients who declined randomization but agreed to join
a self-selection study of their experience.15 Here, we aim to describe (1) differences in characteristics of participants enrolled
in the self-selection cohort compared with a contemporaneously recruited subset of the RCT, (2) outcomes in these 2 cohorts, and (3) reasons for appendectomy in those randomized
to antibiotics vs those who selected antibiotics. Our investigation is primarily a descriptive study that includes an exploratory, post hoc analysis (without specific hypothesis testing) to
consider the association between self-selection cohort status and
the rate of appendectomy after initiating antibiotics.

Methods
The Patient-Centered Outcomes Research Institute (PCORI)–
funded CODA RCT and its self-selection cohort have been
E2

Key Points
Question How do the characteristics and outcomes of patients
randomized to receive antibiotics for appendicitis compare with
those of patients who declined randomization and self-selected
their treatment?
Findings In this secondary analysis of the CODA randomized
clinical trial (RCT), including 1094 randomized patients and a
contemporaneously recruited self-selection cohort consisting of
510 patients who declined randomization, clinical characteristics
and most outcomes were similar between RCT participants and
those who selected treatment. Several sociodemographic
characteristics differed between the RCT and self-selection
cohorts.
Meaning Substantially similar outcomes across the randomized
and self-selection cohorts of CODA suggest that the RCT results
are generalizable to the community at large.

previously described.15 The University of Washington Institutional Review Board approved the study with reciprocal or parallel approvals from the institutional review boards of the CODA
sites; the Consolidated Standards of Reporting Trials
(CONSORT) reporting guideline was followed. The
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guideline was followed for
the self-selection cohort study. Only 23 of 25 CODA sites
participated in both the RCT and self-selection cohort study
(eAppendix 2 in Supplement 1). Recruitment of sites was
staggered, with patients enrolled in the CODA trial from May
3, 2016, to February 5, 2020. Recruitment for the selfselection cohort ended on March 5, 2019. Participant follow-up
was ended in 2021. All participants were eligible for at least 1
year of follow-up.

Study Population
Research coordinators evaluated the electronic medical records of all English- or Spanish-speaking adults (aged ≥18 years)
with imaging-confirmed appendicitis in emergency departments (EDs). Exclusion criteria included contraindications to
surgery, septic shock, diffuse peritonitis, radiographic evidence of severe phlegmon (if the surgeon determined that a
more extensive resection was likely), walled-off abscess, significant amounts of free air or ascites, suspicion of neoplasm,
or recurrent appendicitis. Sites were regularly audited to confirm that all patients with appendicitis were screened. Sociodemographic, clinical, and radiographic characteristics were
assessed through patient self-report and electronic medical records and have been previously described.10,15 To more completely describe the patient population, self-reported race and
ethnicity were included in Table 1.

Consent and Randomization Process
As part of the consent process, eligible patients viewed a standardized informational video (or pamphlet) in English17 or
Spanish.18 Patients provided written consent. Those consenting to the RCT were assigned to treatment based on a randomization independently provided by the data coordinating center. Those who declined randomization but met the same

JAMA Surgery Published online May 25, 2022 (Reprinted)

© 2022 American Medical Association. All rights reserved.

Downloaded From: https://jamanetwork.com/ by a Henry Ford Health System User on 06/24/2022

jamasurgery.com

Self-selection vs Randomized Assignment of Treatment for Appendicitis

Original Investigation Research

Table 1. Baseline Participant Characteristics of the Self-selection and Randomized Clinical Trial Cohortsa
Characteristic

RCT subset
(n = 1094)b

All self-selection
(n = 510)

Self-selection-antibiotics
(n = 257)

Self-selection-appendectomy
(n = 253)

Age, mean (95% CI), y

38.2 (37.4-39.0)

35.8 (34.5-37.1)

37.1 (35.2-39.0)

34.4 (32.8-36.1)

Male

65 (62-67)

57 (53-61)

60 (54-66)

54 (48-60)

Female

35 (33-38)

43 (39-47)

40 (34-46)

46 (40-52)

Sex, % (95% CI)

Race, % (95% CI)c
American Indian or Alaska Native

2 (1-3)

1 (0-2)

0 (0-2)

1 (0-3)

Asian

6 (5-8)

10 (8-13)

14 (10-19)

7 (4-11)

Black

8 (6-10)

6 (5-9)

8 (5-12)

5 (3-8)

Native Hawaiian or Pacific Islander

0.5 (0-1)

0

0

0

White

59 (56-62)

61 (56-65)

57 (51-63)

65 (59-71)

Other

21 (19-24)

17 (14-21)

16 (12-21)

19 (14-24)

Multiple

4 (3-5)

5 (3-7)

5 (3-9)

4 (2-7)

No

57 (54-60)

70 (66-74)

74 (69-79)

66 (60-72)

Yes

43 (40-46)

30 (26-34)

26 (21-31)

34 (28-40)

72 (66-77)

Hispanic ethnicity, % (95% CI)

Primary language, % (95% CI)
English

64 (61-67)

72 (68-76)

72 (66-77)

Spanish

31 (28-34)

19 (16-23)

15 (11-20)

24 (19-29)

Other

5 (4-6)

9 (6-11)

13 (9-17)

4 (2-8)

Employed

73 (70-76)

70 (65-73)

66 (60-72)

73 (67-78)

Student

6 (5-7)

10 (8-13)

13 (9-17)

8 (5-11)

Retired or other

21 (19-24)

20 (17-24)

21 (17-27)

19 (15-25)

Some college or more

63 (60-65)

72 (68-76)

71 (66-77)

72 (66-77)

No college

37 (35-40)

28 (24-32)

29 (23-34)

28 (23-34)

Employment, % (95% CI)

Education, % (95% CI)

Insurance, % (95% CI)
Commercial

45 (42-48)

53 (48-57)

52 (46-58)

53 (47-59)

Medicare or Tricare

13 (11-15)

12 (10-16)

11 (8-16)

14 (10-19)

Medicaid or state

17 (15-19)

14 (11-17)

13 (10-18)

14 (11-19)

Other or none

25 (22-27)

21 (18-25)

24 (19-29)

19 (15-24)

No

57 (53-60)

64 (59-68)

64 (57-70)

63 (56-70)

Yes

43 (40-47)

36 (32-41)

36 (30-43)

37 (30-44)

No

31 (28-34)

41 (36-45)

40 (34-46)

41 (35-47)

Yes

69 (66-72)

59 (55-64)

60 (54-66)

59 (53-65)

0

37 (34-40)

43 (39-47)

42 (36-48)

44 (38-50)

≥1

63 (60-66)

57 (53-61)

58 (52-64)

56 (50-62)

Body mass index, mean (95% CI)d

28.9 (28.5-29.3)

27.6 (27.0-28.3)

27.3 (26.5-28.2)

27.9 (26.9-28.9)

Average pain in the previous 7 d,
mean (95% CI)e

5.3 (5.1-5.5)

5.2 (4.9-5.4)

4.9 (4.5-5.2)

5.5 (5.1-5.9)

Maximum pain recorded in the
emergency department,
mean (95% CI)

7.2 (7.1-7.4)

7.0 (6.8-7.3)

6.6 (6.3-6.9)

7.5 (7.3-7.8)

No

74 (72-77)

70 (66-74)

75 (69-80)

65 (59-70)

Yes

26 (23-28)

30 (26-34)

25 (20-31)

35 (30-41)

Below the federal poverty level or a
Medicaid beneficiary, % (95% CI)

Worried about out-of-pocket bills,
% (95% CI)

No. of dependents, % (95% CI)

Appendicolith present on radiological
imaging, % (95% CI)

(continued)
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Table 1. Baseline Participant Characteristics of the Self-selection and Randomized Clinical Trial Cohortsa (continued)
RCT subset
(n = 1094)b

All self-selection
(n = 510)

Self-selection-antibiotics
(n = 257)

Self-selection-appendectomy
(n = 253)

Appendiceal width on radiological
imaging, mean (95% CI)

11.4 (11.2-11.6)

11.3 (11.0-11.5)

11.2 (10.8-11.6)

11.4 (11.0-11.7)

EQ-5D, mean (95% CI)

0.69 (0.68-0.71)

0.66 (0.64-0.69)

0.71 (0.69-0.74)

0.61 (0.58-0.65)

Alvarado score, mean (95% CI)f

6.6 (6.5-6.7)

6.6 (6.4-6.7)

6.3 (6.1-6.5)

6.8 (6.6-7.0)

Characteristic

antibiotics, 7 surgery) were missing data on average pain in the previous 7
days; 142 in the RCT subset and 62 in the self-selection cohort (26 antibiotics,
36 surgery) were missing data on maximum pain recorded in the emergency
department; 140 in the RCT subset and 76 in the self-selection cohort (41
antibiotics, 35 surgery) were missing data on appendiceal width; and 65 in the
RCT subset and 25 in the self-selection cohort (9 antibiotics, 16 surgery) were
missing data on the EQ-5D.

Abbreviations: EQ-5D, EuroQoL Five-Dimension; RCT, randomized clinical trial.
a

Twelve participants in the RCT subset and self-selection participants in the
self-selection cohort (3 antibiotics, 2 surgery) were missing data on race; 1 in
the self-selection cohort (antibiotics arm) was missing data on Hispanic
ethnicity; 5 in the RCT subset and 3 in the self-selection cohort (2 antibiotics, 1
surgery) were missing data on employment; 16 in the RCT subset and 15 in the
self-selection cohort (5 antibiotics, 10 surgery) were missing data on
education; 24 in the RCT subset and 17 in the self-selection cohort (6
antibiotics, 11 surgery) were missing data on insurance; 238 in the RCT subset
and 107 in the self-selection cohort (53 antibiotics, 54 surgery) were missing
data on being below the federal poverty level or a Medicaid beneficiary; 26 in
the RCT subset and 14 in the self-selection cohort (5 antibiotics, 9 surgery)
were missing data on whether they were worried about out-of-pocket bills; 38
in the RCT subset and 22 in the self-selection cohort (9 antibiotics, 13 surgery)
were missing data on number of dependents; 170 in the RCT subset and 86 in
the self-selection cohort (63 antibiotics, 23 surgery) were missing data on
body mass index; 35 in the RCT subset and 15 in the self-selection cohort (8

eligibility criteria were offered participation in a companion
self-selection cohort study (eFigure in Supplement 1).15 By design, the self-selection cohort study included approximately
250 patients in each treatment group, which we limited to a
fixed number enrolled each quarter and in each treatment
group to ensure contemporaneous recruitment with the RCT.
Two sites began enrollment in the RCT after self-selection cohort study enrollment was completed; these RCT participants are not included in this analysis.

Treatment
Antibiotics
A minimum of 24 hours receiving an intravenous antibiotic formulation was required (given as a q4-q24–hour regimen) followed by oral antibiotics, for a 10-day course. Clinical teams
selected antibiotics from the Surgical Infection Society and the
Infectious Disease Society of America guidelines for intraabdominal infections.19,20 Standard discharge criteria were applied to all patients: tolerance of liquids, adequate pain control, and improving clinical condition. Some patients met the
criteria for discharge without hospital admittance, leaving the
ED once discharge criteria were met. Appendectomy was recommended if diffuse peritonitis or septic shock developed at
any time, if worsening signs and symptoms developed after
48 hours of antibiotics, or if the patient declined to continue
in the randomized group. Absent these conditions, participants in both the randomized and self-selection studies were
encouraged to continue taking antibiotics; the decision to perform appendectomy was ultimately made by the treating
surgeon.
Appendectomy
Minimally invasive and open approaches were allowed. Preoperative antibiotics and usual postoperative care and discharge criteria were used, including the option of discharge
from recovery room to observational unit or home.
E4

b

Contemporaneously recruited participants in the RCT.

c

Participants who reported more than 1 race are listed as multiracial; those who
reported just 1 race are listed as having that race. Two hundred ninety-eight
(93%) of those reporting “other” race were Hispanic.

d

Calculated as weight in kilograms divided by height in meters squared.

e

Ranges from 0 to 10, where 0 is “no pain” and 10 is “worst pain imaginable.”

f

Ranges from 0 to 10, with higher scores indicating a higher probability of
appendicitis.

Outcomes and Measures
Participants were contacted by telephone, mail, or email at 24
hours after discharge and were surveyed at 1, 2, and 4 weeks,
then quarterly for 1 year, at 18 months, and then yearly thereafter. The EuroQoL Five-Dimension (EQ-5D),16 the primary
analytic outcome, was assessed at 4 weeks. Other outcomes
included severe adverse events and complications of appendectomy defined using National Surgical Quality Improvement Program criteria.21 Additionally, antibiotic-related events
were defined as involving an in-person health care encounter, appendectomy, prescriptions for antibiotics beyond index treatment, ED and urgent care visits for related signs and
symptoms, hospitalizations, and days of missed work or school
(for patient and/or caregiver); all events were assessed. All severe adverse events were adjudicated by an independent safety
monitor to determine if they were related to appendicitis and/or
treatment.

Statistical Analysis
Demographic details, clinical characteristics, and participant
perceptions of treatment success and safety were collected at
baseline and were described using proportions and corresponding 95% CIs for categorical variables. Means and CIs were
calculated for continuous measures. As this was intended to
be a descriptive analysis of characteristics and outcomes for
those in the contemporaneously recruited RCT and selfselection cohorts and between those who selected antibiotic
treatment and appendectomy, the sample size of the selfselection cohort was not determined to power comparisons
between these groups.
Outcomes are presented using an intention-to-treat framework. Confidence intervals were calculated using the t test,
Wilson method for proportions, and Poisson exact counts for
continuous, binary, and count data, respectively. All comparisons were unadjusted, except where noted, and those who
were lost to follow-up or did not report data were generally
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excluded from analyses of those outcomes. A Kaplan-Meier cumulative incidence curve was used to estimate the incidence
of appendectomy in the antibiotics arms of both cohorts, overall and by appendicolith status (prespecified analysis). Appendectomy rates through 2 years are shown. A post hoc analysis
assessed the association between sociodemographic variables and the odds of participating in the randomized cohort
(vs self-selection) with and without direct covariate adjustment for site. Another post hoc analysis assessed the association between self-selection cohort status (compared with RCT
participation) and the odds of appendectomy at 30 days and 1
year, adjusting for site and appendicolith on imaging. Multiple imputation using chained equations algorithms in R software (eAppendix 1 in Supplement 1) was used to account for
missing data. Data are current as of March 28, 2021. All analyses were performed using R statistical software, version 4.0.3
(R Foundation for Statistical Computing).

Results
The self-selection cohort included 510 patients (mean age, 35.8
years [95% CI, 34.5-37.1 years]; 218 female [43%; 95% CI, 39%47%] and 292 male [57%; 95% CI, 53%-61%]; 3 American Indian or Alaska Native [1%; 95% CI, 0-2%], 52 Asian [10%; 95%
CI, 8%-13%], 32 Black [6%; 95% CI, 5%-9%], 307 White [61%;
95% CI, 56%-65%], 88 of other race [17%; 95% CI, 14%-21%],
and 23 of multiple races [5%; 95% CI, 3%-7%]) recruited at 23
study sites who selected appendectomy (n = 253) or antibiotics (n = 257). Using only RCT data from sites that were contemporaneously recruiting patients for the RCT and selfselection cohort, 5679 patients were screened, and 31.9% of
3429 eligible participants agreed to randomization to appendectomy (544) or antibiotics (550). These 1094 RCT participants represent 70.5% of the previously described RCT cohort of 1552 participants and had substantially similar clinical
and demographic characteristics compared with the full RCT
cohort (mean age, 38.2 years [95% CI, 37.4-39.0 years]; 386 female [35%; 95% CI, 33%-38%] and 708 male [65%; 95% CI,
62%-67%]; 17 American Indian or Alaska Native [2%; 95% CI,
1%-3%], 66 Asian [6%; 95% CI, 5%-8%], 86 Black [8%; 95% CI,
6%-10%], 5 Native Hawaiian or other Pacific Islander [0.5%;
95% CI, 0%-1%], 638 White [59%; 95% CI, 56%-62%], 231 of
other race [21%; 95% CI, 19%-24%], and 39 of multiple races
[4%; 95% CI, 3%-5%]).10
Compared with those who were randomized, participants who declined randomization and opted for the selfselection cohort (Table 1) were younger (mean age, 35.8 [95%
CI, 34.5-37.1] vs 38.2 [95% CI, 37.4-39.0] years), more often female (218 [43%; 95% CI, 39%-47%] vs 386 [35%; 95% CI, 33%38%]), less often Hispanic (152 [30%; 95% CI, 26%-34%] vs 471
[43%; 95% CI, 40%-46%]), less often Spanish speakers (99
[19%; 95% CI, 16%-23%] vs 336 [31%; 28%-34%]), and more often students (51 [10%; 95% CI, 8%-13%] vs 64 [6%; 95% CI, 5%7%]); reported more formal schooling (some college or more,
355 [72%; 95% CI, 68%-76%] vs 674 [63%; 95% CI, 60%65%]); more often had commercial insurance (259 [53%; 95%
CI, 48%-57%] vs 486 [45%; 95% CI, 42%-48%]); and had lower
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body mass index (27.6 [95% CI, 27.0-28.3] vs 28.9 [28.5-29.3],
calculated as weight in kilograms divided by height in meters
squared), fewer out-of-pocket health care concerns (295 [59%;
95% CI, 55%-64%] vs 738 [69%; 66%-72%]), and fewer dependents (667 [57%; 53%-61%] vs 279 [63%; 60%-66%]).
Conversely, clinical characteristics, including signs and
symptoms and laboratory values that are presumed markers
of appendicitis severity (eg, white blood cell count [eTable 1
in Supplement 1]), were similar across the 2 cohorts. A post hoc
analysis of sociodemographic characteristics found that a high
school degree or less (unadjusted OR, 0.66; 95% CI, 0.520.83; OR adjusted for site, 0.85; 95% CI, 0.64-1.13) and commercial insurance (unadjusted OR, 1.33; 95% CI, 1.07-1.65; OR
adjusted for site, 0.96; 95% CI, 0.72-1.28) were associated with
cohort (self-selection vs randomized), but those associations
were attenuated after adjusting for site. Spanish as primary language, however, was less common in the self-selection cohort than in the randomized cohort, even after adjustment for
site (unadjusted OR, 0.50; 95% CI, 0.37-0.65; OR adjusted for
site, 0.66; 95% CI, 0.47-0.94).
In the self-selection cohort, the antibiotics and appendectomy groups (Table 1) had similar demographic characteristics (eTable 1 in Supplement 1). Those in the self-selection appendectomy group reported greater maximum pain in the ED
(7.5 [95% CI, 7.3-7.8] vs 6.6 [95% CI,6.3-6.9] points; scores range
from 0 to 10, where 0 is “no pain” and 10 is “worst pain imaginable”), had a higher Alvarado score (6.8 [95% CI, 6.6-7.0] vs
6.3 [95% CI, 6.1-6.5] points; scores range from 0 to 10, with
higher scores indicating a higher probability of appendicitis),
more rebound pain (65 patients [26%; 95% CI, 21%-31%] vs 37
patients [14%; 95% CI, 11%-19%]), and a higher white blood cell
count (13.6 [95% CI, 13.1-14.1] vs 13.0 [95% CI, 12.5-13.5]) than
those in the self-selection antibiotics group; the clinical importance of some of these differences is uncertain. Appendicolith was more common in the self-selection appendectomy
group than in the self-selection antibiotics group (65 [35%; 95%
CI, 30%-41%] vs 89 [25%; 95% CI, 20%-31%]), and the baseline EQ-5D score was also worse in the self-selection appendectomy group (0.61 [95% CI, 0.58-0.65] vs 0.71 [95% CI, 0.690.74]). See eTable 2 in Supplement 1 for characteristics of the
contemporaneously recruited RCT cohort by group.
Most outcomes at 30 days were similar between the selfselection cohort and the RCT cohort (Table 2). The 30-day
EQ-5D was nearly identical in both the self-selection antibiotics and RCT antibiotics groups, as well as in the selfselection appendectomy and RCT appendectomy groups. Time
until resolution of symptoms was similar between treatment
groups, whether patients selected or were randomized to treatment. There appeared to be differences between participants
in the self-selection and RCT cohorts regarding length of index hospitalization, but ED visits and the number of ED or urgent care visits were small with overlapping CIs. Compared with
those participants randomized to antibiotics, those who chose
antibiotics appeared to have fewer hospitalizations after initial treatment. Among those who selected antibiotics, 38 had
undergone appendectomy by 30 days (15.3%; 95% CI, 10.7%19.7%), compared with 155 patients among those randomized to antibiotics (19.2%; 95% CI, 15.9%-22.5%), for an
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Table 2. Intention-to-Treat Comparison of Patient-Reported Outcomes, Clinical Outcomes, and Time Spent in Health Care
Between Those in the Self-selection Cohort and the Contemporaneously Recruited Randomized Clinical Trial Subseta
Antibiotics

Appendectomy

Self-selection

RCT subsetb

Self-selection

RCT subsetb

0.92 (0.90-0.94)

0.93 (0.91-0.94)

0.92 (0.90-0.94)

0.92 (0.91-0.93)

By 7 d

53 (47-59)

49 (45-53)

44 (37-50)

51 (47-55)

By 14 d

72 (66-78)

67 (63-71)

62 (55-68)

67 (63-71)

By 30 d

72 (66-78)

71 (67-75)

66 (59-72)

72 (67-75)

Days from emergency department arrival to
discharge for index treatment, mean (95% CI)

1.51 (1.31-1.71)

1.47 (1.33-1.61)

1.76 (1.49-2.03)

1.61 (1.50-1.72)

Any hospitalization after index treatment
through 90 d, % (95% CI)

11 (8-16)

26 (22-30)

6 (4-11)

5 (3-8)

Days in hospital after index treatment
through 90 d (95% CI)

0.23 (0.17-0.31)

0.72 (0.65-0.81)

0.08 (0.04-0.13)

0.11 (0.08-0.14)

Any visit to an emergency department or urgent
care clinic after index treatment within 90 d,
% (95% CI)

7 (4-12)

9 (7-13)

6 (4-11)

5 (3-8)

Visits to emergency department or urgent care
clinic after index treatment within 90 d,
No. (95% CI)

0.07 (0.04-0.12)

0.11 (0.08-0.14)

0.07 (0.03-0.11)

0.04 (0.03-0.07)

Participant

3.85 (3.54-4.18)

5.68 (5.42-5.95)

8.12 (7.59-8.68)

7.86 (7.54-8.18)

Caregiver

0.96 (0.81-1.13)

1.46 (1.33-1.59)

2.2 (1.93-2.49)

2.03 (1.87-2.19)

3.49 (1.99-5.66)

Quality of life at 30 d
EQ-5D, mean (95% CI)
Resolution of symptoms, % (95% CI)

Time in health care

Days missed work within 90 d (95% CI)

Serious adverse events within 90 d
No. of events per 100 participants (95% CI)

3.65 (1.58-7.2)

3.93 (2.37-6.14)

3.32 (1.33-6.84)

Any, % (95% CI)

3 (1-6)

3 (2-5)

3 (2-7)

3 (2-5)

2.74 (1.01-5.96)

9.11 (6.62-12.23)

4.27 (1.95-8.10)

3.92 (2.32-6.20)

No. of NISQIP events per 100 participants
within 90 d (95% CI)

antibiotics, 438 in the RCT antibiotics subset, 190 in the self-selection surgery,
and 417 in the RCT surgery subset groups contributed data to the analysis of
days in hospital after index treatment through 90 days; 193 in the
self-selection antibiotics, 434 in the RCT antibiotics subset, 186 in the
self-selection surgery, and 415 in the RCT surgery subset groups contributed to
the analysis of any visit to an emergency department or urgent care clinic after
index treatment within 90 days; 192 in the self-selection antibiotics, 432 in the
RCT antibiotics subset, 184 in the self-selection surgery, and 410 in the RCT
surgery subset groups contributed to the analysis of number of visits to an
emergency department or urgent care clinic after index treatment within 90
days; 145 in the self-selection antibiotics, 314 in the RCT antibiotics subset,
106 in the self-selection surgery, and 298 in the RCT surgery subset groups
contributed data to the analysis of days the participant missed work; 144 in
the self-selection antibiotics, 335 in the RCT antibiotics subset, 112 in the
self-selection surgery, and 318 in the RCT surgery subset groups contributed
data to the analysis of days the participant’s caregiver missed work; and 219 in
the self-selection antibiotics, 483 in the RCT antibiotics subset, 211 in the
self-selection surgery, and 459 in the RCT surgery subset groups contributed
data to the analysis of number of serious adverse events within 90 days.

Abbreviations: EQ-5D, EuroQoL Five-Dimension; NISQIP, National Surgical
Quality Improvement Program; RCT, randomized clinical trial.
a

Two hundred twenty-three participants in the self-selection antibiotics, 493 in
the RCT antibiotics subset, 211 in the self-selection surgery, and 467 in the RCT
surgery subset groups contributed data to the analysis of EQ-5D at 30 days;
230 in the self-selection antibiotics, 515 in the RCT antibiotics subset, 216 in
the self-selection surgery, and 498 in the RCT surgery subset groups
contributed data to the analysis of resolution of symptoms by 7 days; 218 in
the self-selection antibiotics, 497 in the RCT antibiotics subset, 213 in the
self-selection surgery, and 498 in the RCT surgery subset groups contributed
data to the analysis of resolution of symptoms by 14 days; 221 in the
self-selection antibiotics, 484 in the RCT antibiotics subset, 209 in the
self-selection surgery, and 468 in the RCT surgery subset groups contributed
data to the analysis of resolution of symptoms by 30 days; 257 in the
self-selection antibiotics, 549 in the RCT antibiotics subset, 252 in the
self-selection surgery, and 541 in the RCT surgery subset groups contributed
data to the analysis of index stay days; 205 in the self-selection antibiotics,
448 in the RCT antibiotics subset, 193 in the self-selection surgery, and 421 in
the RCT surgery subset groups contributed data to the analysis of any
hospitalization after index through 90 days; 202 in the self-selection

absolute difference of 3.9% (95% CI, −1.7% to 9.5%). At 1 year,
the absolute difference in the rate of appendectomy was 6.7%
(95% CI, −0.8% to 14.2%). Observed differences (Figure) across
study groups appeared to be associated with the nonappendicolith subgroup rather than the appendicolith subgroup
(Table 3). To better understand this observed difference, we
used an exploratory post hoc conditional logistic regression
analysis combining the self-selection and contemporaneous
RCT cohorts to evaluate the association of self-selection cohort status and appendectomy by 30 days and 1 year. After adjusting for site and appendicolith status, the OR for appendecE6

b

Contemporaneously recruited participants in the RCT.

tomy among those receiving antibiotics in the self-selection
cohort vs those receiving antibiotics in the RCT at 30 days was
0.88 (95% CI, 0.56-1.37) and at 1 year was 0.72 (95% CI, 0.511.03).
The distribution of reasons for appendectomy (confirmed by the participant) were similar between the RCT and
self-selection cohorts, with 10 (29%; 95% CI, 16%-45%) of all
appendectomies in the self-selection cohort vs 24 (23%; 95%
CI, 16%-32%) in the RCT cohort reported for nonclinical reasons. Pathology reports confirmed the diagnosis of appendicitis in 32 (97%; 95% CI, 92%-99%) of the antibiotics-
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Figure. Cumulative Incidence of Appendectomy in Self-selection
Antibiotics Cohort and Antibiotics–Randomized Clinical Trial (RCT)
Subset Cohort

Cumulative incidence
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Includes all appendectomies, even those performed for nonclinical reasons. The
RCT subset consists of those participants in the RCT who were recruited
contemporaneously with participants in the self-selection cohort from the sites
that participated in both studies. Shaded areas represent 95% CIs.

assigned participants and 99 (91%; 95% CI, 78%-97%) of those
who selected antibiotics. A repeated course of antibiotics was
administered in 18 patients receiving antibiotics (11%) in the
RCT and 54 (8%) in the self-selection cohorts at 4 weeks.

Discussion
The CODA RCT and parallel cohort composed of those who declined randomization but agreed to join the self-selection study
represent a diverse group of participants. Those declining randomization more often had characteristics associated with better access to health care services (eg, commercial insurance,
higher income, English speaking). For most outcomes (including EQ-5D and resolution of symptoms), results were similar
between the RCT and the self-selection cohort, supporting the
generalizability of the RCT results to similar populations. Some
clear differences in outcomes were observed (eg, health care
utilization), and other outcomes with smaller differences may
be variably interpreted (appendectomy rate after initiating antibiotics). Some outcomes, such as complications, occurred too
infrequently to compare rates between cohorts. The reasons
behind observed differences and the extent to which such differences will affect patient and clinical decision-making
remain to be determined.
Parallel observational cohort studies have been deployed
in tandem with RCTs for multiple interventions (tonsillitis,22
pregnancy,23,24 Achilles’ tendon rupture,25 ankle fracture,26
diverticulitis,27 and various spine operations).28-30 They can provide context and external validity for RCTs31 and address population differences as well as the association of treatment selection with outcomes. Parallel observational cohorts are especially
relevant for small RCTs when selection factors may be more extreme. In a prior larger-scale pragmatic RCT (SPORT trial of spine
surgery), the parallel observational cohort was important in understanding outcomes because of high rates of crossover.28,29

A recent meta-analysis found that observational cohorts conducted in parallel with RCT studies had higher participation rates
and populations more reflective of the at-risk group than the
RCT.32 Delevry et al33 also examined the influence of treatment selections, finding improved outcomes among patients
who received their chosen therapy compared with those who
were randomized. To our knowledge, our study is the first randomized trial of appendicitis treatment with a parallel observational (self-selection) cohort.
A first goal in recruiting a parallel self-selection cohort was
to give context to the population willing to randomize, recognizing that demographic and clinical features of those who randomize may be different from the general at-risk population.
Although this self-selection cohort may provide context, it, too,
was not composed of the general, at-risk population. Instead,
this group included those who were eligible for the CODA trial,
observed a consent video15 presenting risks and benefits of both
treatments, declined participation in the RCT, and then agreed
to join an observational research study. The extent to which
these aspects of cohort recruitment affected their characteristics or outcome is unknown, but we observed that practice
site was important. Site effects may have included varied recruitment practices and their influence on enrollment in the
RCT. Furthermore, cultural norms and perceptions of power
and privilege may have resulted in some people seeking out
clinical trials while others may have been uncomfortable refusing involvement. Explaining this observation is made more
complex by underinsurance and systemic barriers to health
care. Some who are underinsured or historically and currently marginalized may anticipate benefit from trial participation (eg, perception of better follow-up and access to innovation). The findings of overrepresentation of some minoritized
groups, including people experiencing poverty, in the randomized group is in distinction to the observation that Black
individuals, Indigenous individuals, those of other minoritized racial and ethnic groups, individuals who speak Spanish, and those living in poverty34 are often underrepresented
in RCTs. It remains to be determined whether specific aspects of the CODA recruitment strategy (eg, requiring refusal
to participate in the RCT before offering the self-selection cohort), differential interest in obtaining the antibiotic option,
or other aspects of care affected higher proportional recruitment to the RCT in these subgroups. Health care access and
patient experience is influenced by systematic barriers (including racism and xenophobia) within our health systems.
Ensuring that people from diverse backgrounds have the opportunity to participate in clinical trials is important to understanding disparate experiences and clinical outcomes, and it
is a critical piece in advancing health equity.35 In addition, it
is essential that all potential participants are empowered to
refuse participation.
A second rationale for conducting a parallel observational
cohort study with the RCT was to provide context for outcomes identified in the RCT—especially subjective outcomes associated with antibiotics—and to explore differences that might
be associated with selecting, rather than being randomized to,
treatment.36 A direct comparison of outcomes between the selfselection and RCT cohorts for either treatment is limited by
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Table 3. Cumulative Incidence (95% CI) of Appendectomy in Self-selection and Randomized Clinical Trial (RCT)
Subset Cohorts
Cumulative incidence, % (95% CI)
Self-selection

RCT subseta

Difference

48 h

10.5 (6.6 to 14.2)

11.1 (8.5 to 13.7)

0.6 (−4.0 to 5.2)

30 d

15.3 (10.7 to 19.7)

19.2 (15.9 to 22.5)

3.9 (−1.7 to 9.5)

1y

33.2 (27 to 38.9)

39.9 (35.6 to 43.9)

6.7 (−0.8 to 14.2)

2y

37.1 (30.6 to 43)

46.1 (41.6 to 50.3)

9 (0.9 to 17.1)

48 h

7.0 (3.2 to 10.5)

7.9 (5.2 to 10.5)

0.9 (−3.6 to 5.4)

30 d

11.2 (6.6 to 15.7)

15.4 (11.8 to 18.9)

4.2 (−1.6 to 10)

1y

26.5 (19.7 to 32.6)

35.3 (30.3 to 39.8)

8.8 (0.6 to 17)

2y

30.2 (23.1 to 36.7)

42.8 (37.5 to 47.6)

12.6 (3.5 to 21.7)

48 h

21.3 (10.3 to 30.9)

20.3 (13.4 to 26.6)

−1.0 (−13.1 to 11.1)

30 d

27.9 (15.7 to 38.3)

30.1 (22.1 to 37.2)

2.2 (−11.3 to 15.7)

1y

54.1 (39.3 to 65.3)

53.0 (43.8 to 60.6)

−1.1 (−16.7 to 14.5)

2y

58.4 (43.2 to 69.6)

55.5 (46.3 to 63.1)

−2.9 (−19.1 to 13.3)

Appendectomy incidence
Overall

Among those without appendicolith
on radiological imaging

Among those with appendicolith
on radiological imaging

a

selection bias and confounding. Nonetheless, a description of
outcomes in both cohorts and treatment groups found that for
most findings—such as overall health status, time to resolution of symptoms, and safety events—results were similar in both
cohorts. These similarities speak to the generalizability of the
trial results and may be reassuring to those considering antibiotics outside of the RCT framework. There appeared to be a lower
rate of subsequent hospitalization in the group that selected antibiotics compared with those randomized to antibiotics. This
outcome may be related to a slightly higher number of negative appendectomy findings (no appendicitis identified in pathologic evaluation) and appendectomy for nonclinical reasons in
the self-selection cohort, but the infrequency of these events
limits interpretation. The 3.9% observed difference in the proportion undergoing appendectomy after initiating antibiotics between those in the self-selection and RCT cohorts prompted a
post hoc analysis adjusting for site effects. That analysis did not
suggest lower odds of appendectomy among those selecting antibiotic treatment. Interpreting these observed differences is
challenging, given the relatively infrequent outcomes, small subgroups, and unbalanced covariates between groups. Although
not measured in CODA, potential site effects that may be relevant to understanding the observed difference include ease of
access to follow-up care, nausea and pain management strategies, encouragement during the early recovery period, and variation in surgeon threshold for offering surgery.
A challenge of patient-centered outcomes research is the degree to which clinicians and patients interpret and prioritize results differently. When planning CODA, patient advisors encouraged us to include subgroups—even if treatment success
might be less than 50% in those groups. The advisors believed
patients would want the information to make an informed decision and that many would choose a treatment if there was any
option to safely avoid surgery. Supporting that perspective is a
recent survey study of 1200 at-risk participants in an online,
E8

Contemporaneously recruited
participants in the RCT.

crowdsourcing community (mTurk). Participants were randomized to review vignettes describing antibiotic treatment that varied the “success rate” in avoiding appendectomy from 90% to
as low as 40%. The vast majority of patients (approximately
80%) were interested in trying antibiotics for appendicitis37
irrespective of the chance of success. This finding may provide
context for how some clinicians and patients may variably consider differences observed for the rates of appendectomy in the
self-selection and randomized cohorts.

Limitations
This study has limitations. To qualify for the self-selection cohort, participants first refused to join the randomized cohort.
This requirement may have influenced the observed differences in participant characteristics and outcomes. Second, not
all sites contributed to both the RCT and self-selection cohort
studies. Because describing differences between the selfselection and randomized cohort was a goal, we created an RCT
subgroup drawn only from sites recruiting contemporaneously. This decision may have introduced selection bias with unclear implications. Third, although we theorized that people refusing randomization and selecting their treatment might be
different at baseline and/or have different outcomes than those
randomized, we did not design the study to explicitly test this
hypothesis. We did not predetermine how much of a difference in any baseline characteristic or outcome (eg, rate of appendectomy after starting antibiotics) would be considered
meaningful or recruit a specific number in the self-selection cohort to test for such differences. As a result, type I and II errors
are a consideration in interpreting these results. Similarly, the
regression analysis that explored the association between selfselection vs the RCT cohort status and appendectomy after starting antibiotics—adjusting for site and appendicolith—was post
hoc and exploratory. Also, we asked participants only why they
did not agree to randomize; we can only speculate on reasons
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behind observed differences in baseline characteristics
between those who did and did not randomize.

Conclusions
Observational cohort studies conducted in parallel to RCTs
aim to help future patients and clinicians determine
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